ChoosingTherapy.com is user-supported. We may earn a commission if you sign up for a service through our links, at no cost to you. Our reviews and comparisons are based on independent research.
- Cognitive behavioral therapy (CBT) built for ADHD is the best-studied non-drug treatment for adults. In a 2025 analysis of 113 trials, it beat placebo on clinician ratings. Stimulants and atomoxetine were the only treatments that helped in the short term on both self-reported and clinician-reported scales.1
- Neurofeedback showed no benefit on blinded ratings, omega-3 had no effect in a Cochrane review, and the coaching studies we found had no comparison group.547
- Brightside Health offers CBT-based therapy and psychiatry for adult ADHD through insurance only. Most insured members pay $25 or less, and its prescribers can add medication, stimulants included, in 11 states.
ADHD treatment without medication usually means therapy, skills training, exercise, better sleep, and support at work or school. Of these, CBT designed for adult ADHD has the most trial evidence. Medication still shows the most consistent effects. Guidelines treat non-drug care as the first step for preschoolers and as a reasonable choice for adults who decide against medication. Brightside Health is an online psychiatry and therapy service where CBT-based therapists and prescribers share one team. Its ADHD care is open only to adults 18 and over using insurance.
If you want ADHD-focused therapy with the option of a medication review later, check whether your insurance covers Brightside.
This article is for information only and is not medical advice. Talk to a doctor or licensed clinician before starting, stopping, or changing any treatment.
Which treatments help adults manage ADHD without medication?
Several non-drug treatments help adults manage ADHD, and CBT designed for ADHD has the strongest trial evidence among them. The exercise and sleep trials below were in children and teens, and whether ADHD counts as a disability for workplace accommodations doesn’t depend on taking medication.
CBT and skills training
A 2025 analysis in Lancet Psychiatry pooled 113 randomized trials in 14,887 adults with ADHD.1 CBT, psychoeducation, mindfulness, and cognitive remediation all beat placebo, with effects between -0.76 and -1.35, but only when a clinician did the rating. On the scales adults filled in themselves, none of the four beat placebo. Stimulants and atomoxetine were the only treatments that improved core symptoms in the short term on both kinds of rating.
Therapy trials also can’t be blinded, so participants know which treatment they got.
Exercise
A 2026 meta-analysis of 39 randomized trials in 1,836 children and teens aged 6 to 18 found that exercise improved ADHD symptoms.2 Closed-skill exercise, as the authors call it, improved core symptoms (an effect of -0.54), and open-skill exercise improved executive function (-0.68). They estimate a minimum dose of roughly 20 to 25 minutes a day of moderate-intensity exercise, a figure they call exploratory. All these trials were in young people.
Sleep
A randomized trial in 244 children aged 5 to 12 with ADHD and sleep problems tested two sessions of sleep hygiene and behavioral strategies plus a follow-up call.3 Compared with usual care, ADHD symptoms fell more at 3 months (effect size -0.3) and 6 months (-0.4), and fewer children still had moderate to severe sleep problems.
Accommodations at work and school
Under the Americans with Disabilities Act, concentrating, thinking, learning, and working all count as major life activities. Whether an impairment substantially limits them is judged without regard to medication.4 Choosing not to take medication doesn’t change whether ADHD counts as a disability at work. The Job Accommodation Network lists common ADHD accommodations, including:
-
A quiet workspace, noise cancellation or white noise
-
Uninterrupted work time and to-do lists
-
Help with prioritization
-
Timers, apps, and calendars
For children, the American Academy of Pediatrics (AAP) calls school supports a necessary part of any treatment plan, often through an IEP or a 504 plan.5
How non-drug options compare with medication
Medication and CBT show effects of similar size on clinician ratings in adults, but only stimulants and atomoxetine hold up on self-ratings. In these studies, a number further from zero means a bigger change, and a number near zero means little or no change. The studies used different raters, ages, and lengths, so read each number alongside who did the rating.As of October 2026, from the studies cited.
|
Treatment |
Who was studied |
Effect on ADHD symptoms |
Rating or study type |
|
Stimulants |
Adults, 12 weeks |
-0.61 clinician, -0.39 self |
Both1 |
|
Atomoxetine (non-stimulant) |
Adults, 12 weeks |
-0.51 clinician, -0.38 self |
Both1 |
|
CBT |
Adults |
-0.76 |
Clinician only1 |
|
Mindfulness |
Adults |
-0.79 |
Clinician only1 |
|
Exercise (closed-skill) |
Ages 6 to 18 |
-0.54 |
Pooled trials2 |
|
Sleep program |
Ages 5 to 12 |
-0.3 at 3 months, -0.4 at 6 months |
Randomized trial3 |
|
Neurofeedback |
Ages 5 to 40 |
0.04, not significant |
Probably blinded raters6 |
|
Omega-3 (PUFA) |
Children and teens |
-0.08, no effect |
Parents7 |
The same 2025 analysis found that ADHD medications did not improve quality of life, and that longer-term evidence is underinvestigated.1
ChoosingTherapy.com may earn a commission from the companies whose services are linked on this page.
Online Therapy and Medication for Depression and Anxiety
Brightside Health offers therapy, psychiatry, or both, with insurance accepted from major plans. Start with a free assessment and see your options. Start free assessment
Treatments with weak or missing evidence
Some popular approaches have little support once trials are blinded or controlled. The AAP’s 2019 guideline lists mindfulness, cognitive training, diet modification, EEG biofeedback, and supportive counseling as having too little evidence to recommend, or little to no benefit, for children and teens.5
ADHD coaching
CHADD, the national ADHD nonprofit, describes coaching as a complement to medication and other treatment, focused on planning, time management, organization, and problem-solving. Coaches don’t need a license. One 2026 study of 42 adults reported medium to large gains after 12 sessions, but without a control group it can’t separate coaching from time and expectation.8 We found no randomized trial of coaching for adults with ADHD.
Neurofeedback
A 2025 JAMA Psychiatry review of 38 randomized trials in 2,472 people aged 5 to 40 found no significant improvement in ADHD symptoms when the raters probably didn’t know who got the treatment.6 Trials using standard protocols showed a small effect of 0.21. The authors concluded that neurofeedback did not meaningfully help people with ADHD at the group level.
Diet and omega-3
A 2023 Cochrane review of 37 trials in more than 2,374 children and teens found high-certainty evidence that omega-3 and related supplements had no effect on parent-rated ADHD symptoms.7 NICE, the UK’s guideline body, tells clinicians not to offer fatty acid supplements for ADHD in young people and not to advise removing artificial colorings as a general treatment. It also tells clinicians to tell families there is no evidence on the long-term effects of a “few food” diet.9
Digital therapeutics
EndeavorRx, a prescription digital therapeutic, received FDA authorization in June 2020 to improve attention, as measured by computer-based testing, in children aged 8 to 12, a label extended to ages 13 to 17 in December 2023. Its indication says users may not see benefits in behavioral symptoms such as hyperactivity. The pivotal trial, sponsored by its maker, enrolled 348 children aged 8 to 12, and its main outcome was a score on a computerized attention test.10
Guideline advice on medication
Guidelines recommend medication for most children aged 6 and over and for teens, alongside behavioral treatment, and for adults whose symptoms still cause significant impairment after changes to their environment. Only a clinician who knows your history can apply them to you.
Children and teens (AAP, United States)
The AAP’s 2019 guideline sets out three age bands:10
- Ages 4 to 5: parent training in behavior management and classroom support come first, with methylphenidate considered if problems stay moderate to severe.
- Ages 6 to 11: FDA-approved medication, along with parent training and classroom interventions.
- Ages 12 to 17: FDA-approved medication with the teen’s agreement, with behavioral interventions encouraged alongside.
Adults (NICE, United Kingdom)
NICE recommends offering medication to adults whose ADHD still causes significant impairment in at least one area of life after environmental changes, with lisdexamfetamine or methylphenidate first.9 It recommends considering non-drug treatment for adults who have made an informed choice not to take medication, who have trouble taking it consistently, or for whom it didn’t work or wasn’t tolerated. At a minimum, that means a structured psychological intervention focused on ADHD plus regular follow-up, which may include CBT.
If you already take ADHD medication
NICE says ADHD medication should be reviewed at least once a year, with the person involved in any decision to stop.9 FDA labels warn about stopping some medications abruptly: guanfacine extended-release (Intuniv) can cause a rebound rise in blood pressure, and stopping stimulants such as Adderall after long use can bring fatigue, low mood, and sleep changes.
This article is for information only and is not medical advice. Talk to a doctor or licensed clinician before starting, stopping, or changing any treatment.
How Brightside treats adult ADHD
On Brightside, a psychiatric provider can evaluate and treat adult ADHD, and a therapist can teach symptom-management skills using CBT and other evidence-based methods. You can sign up for psychiatry, therapy,, or both, so you can start with therapy alone.
If you and your prescriber decide on medication, Brightside’s ADHD page lists plans that can include Adderall, Concerta, Strattera, Ritalin and Vyvanse. Stimulants are available only to insured members in 11 states: Arizona, California, Colorado, Florida, Idaho, Kansas, Maine, Michigan, Oregon, Virginia and Washington. Elsewhere, providers may offer non-stimulant options. Our Brightside review covers the service as a whole.
How to start
Brightside’s ADHD page sets out four steps:
- Take the free online assessment and check your coverage.
- Choose a provider by gender, specialty, and more. Switching later is allowed.
- Start treatment by video, sometimes the same day.
- Continue with ongoing care.
What it costs
Brightside says most members pay $25 or less with insurance. ADHD care is available only to members using insurance, so the self-pay plans ($95 a month for psychiatry, $299 for therapy, $349 for both) don’t cover it. Brightside confirmed it takes Aetna, Cigna, Oscar, UnitedHealthcare, and Optum; Blue Cross Blue Shield and Anthem (plan by plan); and Medicaid plans in North Carolina, Nebraska, Oregon, Vermont, and Washington. It does not take Kaiser or Humana.
For comparison, a 2024 estimate from Talkiatry puts a psychiatrist’s first out-of-pocket evaluation at $300 to $500. If your plan is covered, see what Brightside costs with your insurance.
Brightside and Inflow user reviews
Brightside holds 4.0 on Trustpilot from 1,564 reviews, as of October 12, 2026. Most Trustpilot reviews that mention ADHD are one-star. The main complaint comes from people who signed up expecting ADHD medication or a diagnosis and were told Brightside wouldn’t prescribe stimulants or wouldn’t treat ADHD without insurance. Most predate the current 11-state stimulant policy.
Inflow, a CBT-based ADHD app, scores 2.6 on Trustpilot from 116 reviews as of the same date.11 Most recent low ratings describe being charged after canceling a free trial or an annual renewal, with support emails unanswered. Its App Store rating is 4.37 from 5,626 ratings, and positive reviews single out the body-doubling focus rooms.
When Brightside isn’t the right fit
Brightside’s ADHD program serves only insured adults. Brightside also says online care isn’t a good fit for ongoing high-risk self-harm, psychosis, or some cases of bipolar I disorder. If you are in crisis, call or text 988, the Suicide and Crisis Lifeline, or call 911 if you are in immediate danger.
Teens under 18
Brightside sees teens 13 and over, but its ADHD care is for adults 18 and over. For a teen, the AAP guidance above and a school support plan are the starting points, and CHADD runs a free directory of ADHD professionals and a helpline at 1-866-200-8098 (weekdays, 1 to 5 PM ET).
Adults who want a psychiatrist
Talkiatry is a virtual psychiatry practice that treats ADHD. Its psychiatrists can prescribe stimulants where state law allows online prescribing and the clinician believes they would help. It sees only patients whose insurance it accepts, with no self-pay option, no Medicaid, and most patients pay $30 per visit.
Adults who want a self-guided app
Inflow is an app rooted in CBT principles, with five-minute daily exercises, journaling, and prioritization tools. It doesn’t diagnose or treat. A 2026 randomized trial of a CBT-informed app in 154 adults found improvements over a waitlist in inattentive and hyperactive-impulsive symptoms after 8 weeks, but the gains did not extend to functional impairment.12 The abstract doesn’t name the app, and one co-author is a consultant to Inflow’s parent company with stock options.
Inflow doesn’t take insurance. The download is free with a 7-day trial, and the App Store lists $47.99/month or $199.99/year with coaching, or $22.49/month or $95.99/year without. Cancel at least 24 hours before renewal; deleting the app doesn’t cancel it. Our Inflow review and best ADHD apps roundup cover the options in depth.
For insured adults who want CBT-based ADHD therapy with a prescriber on the same platform, start Brightside’s free assessment.
Frequently Asked Questions
Can adults manage ADHD without medication?
Adults can choose to manage ADHD without medication, and UK guidelines recommend a structured psychological program focused on ADHD, which may include CBT, for adults who make that informed choice.9
Does Brightside prescribe stimulants for ADHD?
Brightside prescribes stimulants for ADHD only to insured members in 11 states, when the provider judges them clinically appropriate. Elsewhere,, its providers may offer non-stimulant options, and it does not offer ADHD care to self-pay members.
Does ADHD coaching work?
Whether ADHD coaching works is not yet proven, because the coaching studies we found had no comparison group, and we found no randomized trial in adults.8 CHADD describes coaching as a complement to other treatment, and coaches aren’t required to hold a license.
Does omega-3 or fish oil help ADHD?
Omega-3 supplements do not improve ADHD symptoms in children and teens, according to a 2023 Cochrane review that rated the evidence high-certainty.7
Is neurofeedback an effective ADHD treatment?
Neurofeedback has not proven effective for ADHD in blinded trials, according to a 2025 review of 38 trials.6
Is it safe to stop taking ADHD medication?
Whether it is safe to stop taking ADHD medication depends on the medication and how it is stopped, so NICE says the decision belongs in a regular review with your prescriber that involves you.9 FDA labels warn that stopping some ADHD medications abruptly, such as guanfacine extended-release or stimulants after long use, can cause problems, so talk to your prescriber before making any change.
ChoosingTherapy.com strives to provide our readers with mental health content that is accurate and actionable. We have high standards for what can be cited within our articles. Acceptable sources include government agencies, universities and colleges, scholarly journals, industry and professional associations, and other high-integrity sources of mental health journalism. Learn more by reviewing our full editorial policy.
- Ostinelli EG, et al. (January 2025). Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and component network meta-analysis. Lancet Psychiatry. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/39701638/
- Zhang M, et al. (July 2026). Exercise for core ADHD symptoms and executive functions in children and adolescents with ADHD: A network and dose-response meta-analysis. Journal of Sport and Health Science. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/42480697/
- Hiscock H, et al. (January 2015). Impact of a behavioural sleep intervention on symptoms and sleep in children with attention deficit hyperactivity disorder, and parental mental health: randomised controlled trial. BMJ. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/25646809/
- Legal Information Institute. (October 2026). 42 U.S. Code 12102, Definition of disability. Retrieved from: https://www.law.cornell.edu/uscode/text/42/12102
- American Academy of Pediatrics. (October 2019). Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Retrieved from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7067282/
- Westwood SJ, et al. (February 2025). Neurofeedback for Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis. JAMA Psychiatry. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/39661381/
- Gillies D, et al. (April 2023). Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents. Cochrane Database of Systematic Reviews. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/37058600/
- Ahmann E, et al. (August 2026). Coaching for Adults With ADHD: Gains at a Six-Week Follow-Up. American Journal of Lifestyle Medicine. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/42630464/
- National Institute for Health and Care Excellence. (September 2019). Attention deficit hyperactivity disorder: diagnosis and management (NG87), Recommendations. Retrieved from: https://www.nice.org.uk/guidance/ng87/chapter/Recommendations
- Kollins SH, et al. (April 2020). A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial. Lancet Digital Health. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/33334505/
- Trustpilot. (October 2026). Inflow Reviews. Retrieved from: https://www.trustpilot.com/review/getinflow.io
- Antshel KM, et al. (March 2026). Bridging the Gap: Digital CBT for Adults Managing ADHD Challenges. Journal of Attention Disorders. Retrieved from: https://pubmed.ncbi.nlm.nih.gov/41220055/
We regularly update the articles on ChoosingTherapy.com to ensure we continue to reflect scientific consensus on the topics we cover, to incorporate new research into our articles, and to better answer our audience’s questions. When our content undergoes a significant revision, we summarize the changes that were made and the date on which they occurred. We also record the authors and medical reviewers who contributed to previous versions of the article. Read more about our editorial policies here.
Author: Patricia Duggan, LCMHC
Reviewer: MD review pending